Healthcare News

MILLBRAE, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to...

MicrobiotiX completes MP101's sentinel cohort, with no safety concerns preventing continuation of its first-in-human Phase 1 pneumonia trial.

Professor Marlies Wijsenbeek will give an oral presentation on the quality-of-life outcomes assessed by the LCQ from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with...

WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate...

Ligand to Participate in September Investor Conferences

Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEBFilings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained...

U.S. FDA Orphan Drug Designation underscores darizmetinib’s potential to address a significant unmet need following liver resection  Tuebingen, Germany, August 26, 2026 – HepaRegeniX GmbH...

NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with...

Selskabsmeddelelse 21/2026                                                                   26 august 2026                                                               BESTYRELSESMEDLEMMERS,...

Corline Biomedical AB (”Corline”) publicerar härmed delårsrapporten för perioden januari till juni 2026. Nedan följer en kort sammanfattning av delårsrapporten. Fullständig rapport finns tillgänglig...